Information for Our Community

Whether you are part of our community or are interested in joining us, we welcome you to WashU Medicine.

close  


Visit the News Hub

Holtzman receives Landis Award for Outstanding Mentorship

WashU Medicine neurologist recognized for impact on future scientists

by Heidi LimSeptember 8, 2026

Matt Miller/WashU Medicine

David M. Holtzman, MD, the Barbara Burton and Reuben M. Morriss III Distinguished Professor in the Department of Neurology at WashU Medicine, was selected as a recipient of the Landis Award for Outstanding Mentorship from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health. The annual award was established in 2017 to recognize NINDS-funded investigators for their dedication to mentorship and training.

In a career spanning over three decades, Holtzman has directly mentored more than 80 graduate students, physician-scientist trainees and postdoctoral fellows, as well as many early-career researchers, who have gone onto impactful careers in academia and industry. In addition to running an internationally recognized research program on Alzheimer’s disease mechanisms and treatment and developing novel blood tests for Alzheimer’s diagnosis, Holtzman also serves as director of the Knight Alzheimer Disease Research Center and the Hope Center for Neurological Disorders at WashU Medicine. Despite extraordinary demands on his time, Holtzman is known for always prioritizing the training and mentoring of future scientists.

Holtzman was one of five winners of the 2026 Landis Award. In addition to national recognition, the recipients’ institutions will receive a monetary prize of $100,000 to be used to further the development of future researchers. Holtzman is the second faculty member from WashU Medicine to win the Landis Award; Robert Gereau, PhD, the Dr. Seymour & Rose T. Brown Professor of Anesthesiology, won the award in 2020.

Read more on the Department of Neurology website.

About WashU Medicine

WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 3,100 faculty. Its National Institutes of Health (NIH) research funding portfolio is the second largest among U.S. medical schools and has grown 78% since 2016. Together with institutional investment, WashU Medicine commits over $1.6 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently among the top five in the country, with more than 2,550 faculty physicians practicing at 200 locations. WashU Medicine physicians exclusively staff Barnes-Jewish and St. Louis Children’s hospitals — the academic hospitals of BJC HealthCare — and Siteman Cancer Center, a partnership between BJC HealthCare and WashU Medicine and the only National Cancer Institute-designated comprehensive cancer center in Missouri and southern Illinois. WashU Medicine physicians also treat patients at BJC’s community hospitals in our region. With a storied history in MD/PhD training, WashU Medicine recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.